title: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.
abstract: The signal transducer and activator of transcription, STAT5b, has been implicated in signal transduction pathways for a number of cytokines and growth factors, including growth hormone (GH). Pulsatile but not continuous GH exposure activates liver STAT5b by tyrosine phosphorylation, leading to dimerization, nuclear translocation, and transcriptional activation of the STAT, which is proposed to play a key role in regulating the sexual dimorphism of liver gene expression induced by pulsatile plasma GH. We have evaluated the importance of STAT5b for the physiological effects of GH pulses using a mouse gene knockout model. STAT5b gene disruption led to a major loss of multiple, sexually differentiated responses associated with the sexually dimorphic pattern of pituitary GH secretion. Male-characteristic body growth rates and male-specific liver gene expression were decreased to wild-type female levels in STAT5b-/- males, while female-predominant liver gene products were increased to a level intermediate between wild-type male and female levels. Although these responses are similar to those observed in GH-deficient Little mice, STAT5b-/- mice are not GH-deficient, suggesting that they may be GH pulse-resistant. Indeed, the dwarfism, elevated plasma GH, low plasma insulin-like growth factor I, and development of obesity seen in STAT5b-/- mice are all characteristics of Laron-type dwarfism, a human GH-resistance disease generally associated with a defective GH receptor. The requirement of STAT5b to maintain sexual dimorphism of body growth rates and liver gene expression suggests that STAT5b may be the major, if not the sole, STAT protein that mediates the sexually dimorphic effects of GH pulses in liver and perhaps other target tissues. STAT5b thus has unique physiological functions for which, surprisingly, the highly homologous STAT5a is unable to substitute.
authors.affiliation: Dairy Science Group, AgResearch, Ruakura, Private Bag 3123, Hamilton, New Zealand.
authors.forename: G B
authors.initials: GB
authors.lastname: Udy
authors.forename: R P
authors.initials: RP
authors.lastname: Towers
authors.forename: R G
authors.initials: RG
authors.lastname: Snell
authors.forename: R J
authors.initials: RJ
authors.lastname: Wilkins
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: P A
authors.initials: PA
authors.lastname: Ram
authors.forename: D J
authors.initials: DJ
authors.lastname: Waxman
authors.forename: H W
authors.initials: HW
authors.lastname: Davey
mesh_terms: D000818:Animals; D001835:Body Weight / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008099:Liver / Q000502:physiology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008894:Milk Proteins; D050799:STAT5 Transcription Factor; D012733:Sex Differentiation / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics; D015534:Trans-Activators / Q000235:genetics*; D025521:Tumor Suppressor Proteins
chemical_list: D004268:DNA-Binding Proteins; D008894:Milk Proteins; D050799:STAT5 Transcription Factor; C494092:STAT5A protein, human; C494095:STAT5B protein, human; C494093:Stat5a protein, mouse; C494096:Stat5b protein, mouse; D015534:Trans-Activators; D025521:Tumor Suppressor Proteins